CHIPSCREEN BIOSCIENCES ANNOUNCES NMPA IND APPROVAL FOR NW001, A PD-L1-TARGETED EPIGENETIC IMMUNE-MODULATING ANTIBODY CONJUGATE

Reuters · 2d ago

Please log in to view news